The power of RNAi to create new medicines
We are a pioneer in the development of novel drugs based on RNA interference (RNAi) technology.
Founded in 2006 and part of the PharmaMar group (BME: PHM), our mission is to build a solid and sustainable business and become a leader in the development of RNAi-based products.
We develop new drugs using artificial intelligence with the aim of improving the quality of life of patients.
We are proud to be a company with a highly innovative culture that spans from drug discovery through the entire product life cycle.
Technology at the service of Health
Our transformative science
Our scientific expertise since 2006 in precision-engineered RNAi-based therapeutics has enabled us to drive a positive change in disease treatment.
At the forefront of innovation
We apply the most current scientific tools, such as artificial intelligence, to the development of a new generation of drugs that enable us to address the needs of patients who have limited or inadequate treatment options. We have established a robust and versatile RNAi-based drug discovery platform, SirFinderTM that enables us to develop effective therapies rapidly, cost-effectively and potentially with lower risk relative to traditional approaches.
We are an interdisciplinary team working tirelessly to carry out one goal: improving patient health through cutting-edge science. Our culture reflects our company spirit: scientific excellence, hard work, creativity and diversity. We are committed to organizational flexibility and breaking down barriers in the company. In addition, we have a network of collaborators including research centers, national and international universities along with public or private centers for our developments.
Through science and innovative medicine, Sylentis aims to become one of the leading companies specializing in the discovery, development and manufacture of products based on RNAi technology for the treatment of diseases with a high social impact.
Our ambition is to become the most highly valued company in the industry by patients and healthcare professionals. At Sylentis, we aim to increase our competitiveness as a pharmaceutical company by advancing the therapeutic areas in which we research and develop drugs.
We apply our talent, knowledge and resources to produce new ideas.
The team as the source of our strength
Our company is strong because our employees are different, well-trained and participative.
We strive for growth and transformation by being creative and constructive.
We measure our success by our ability to help people achieve their goals and develop. Patients, physicians, shareholders, employees and customers deserve our best efforts.
Certifications and awards
Officially recognized by the guarantee mark from the Community of Madrid, “Madrid Excelente”, which certifies quality and excellence in company management.
GMP (Good Manufacturing Practice) certified
Sylentis holds a Certificate of Compliance with Good Manufacturing Practices from the Spanish Agency for Medicines and Health Products.